Premaitha Health PLC (LON:NIPT)‘s stock had its “corporate” rating reissued by investment analysts at FinnCap in a note issued to investors on Friday.

Premaitha Health PLC (LON:NIPT) opened at 8.25 on Friday. The firm’s market capitalization is GBX 18.82 million. Premaitha Health PLC has a one year low of GBX 7.00 and a one year high of GBX 14.40. The stock’s 50 day moving average price is GBX 8.51 and its 200 day moving average price is GBX 9.93.

COPYRIGHT VIOLATION WARNING: “Premaitha Health PLC (NIPT) Stock Rating Reaffirmed by FinnCap” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at

About Premaitha Health PLC

Premaitha Health PLC is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company’s product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house.

Receive News & Stock Ratings for Premaitha Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premaitha Health PLC and related stocks with our FREE daily email newsletter.